{
 "PrintNo":"S256","Session":2019,"Chamber":"SENATE","BillType":"Senate","Published":"2019-01-02T16:09:04.023138Z",
 "Status":"IN_SENATE_COMM","Committee":"Consumer Protection",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2020-01-08","Committee":"Consumer Protection"}],
 "Actions":[
  {"Text":"REFERRED TO CONSUMER PROTECTION","Date":"2019-01-09","Chamber":"SENATE"},
  {"Text":"REFERRED TO CONSUMER PROTECTION","Date":"2020-01-08","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":429,"Name":"Timothy M. Kennedy","Short":"KENNEDY"}],"Title":"Relates to price gouging of medicine",
 "Summary":"Prohibits selling a drug subject to a shortage for an unconscionably excessive price.",
 "LawSection":"General Business Law","LawCode":"Add ยง396-rrr, Gen Bus L",
 "ActClause":"AN ACT to amend the general business law, in relation to the price gouging of medicine",
 "PreviousVersions":["S6514-2011","S2138-2013","S4508-2015","S5262-2017"]
}